about
Variants of C-C motif chemokine 22 (CCL22) are associated with susceptibility to atopic dermatitis: case-control studiesIdentification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection.Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsetsEpidemiology of atopic dermatitis in Japan.Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasis.An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis.Levels of immunoglobulin E specific to the major food allergen and chemokine (C-C motif) ligand (CCL)17/thymus and activation regulated chemokine and CCL22/macrophage-derived chemokine in infantile atopic dermatitis on Ishigaki Island.Genetic polymorphism in the TRAF3IP2 gene is associated with psoriasis vulgaris in a Japanese population.Antioxidant Opuntia ficus-indica Extract Activates AHR-NRF2 Signaling and Upregulates Filaggrin and Loricrin Expression in Human Keratinocytes.Alterations in B-cell subsets in pediatric patients with early atopic dermatitis.Incidence, serum IgE and TARC/CCL17 levels in atopic dermatitis associated with other allergic diseases: an update from the Ishigaki cohort.Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin.An association study of 36 psoriasis susceptibility loci for psoriasis vulgaris and atopic dermatitis in a Japanese population.T cell-specific overexpression of interleukin-27 receptor α subunit (WSX-1) prevents spontaneous skin inflammation in MRL/lpr mice.Accelerated T-cell activation and differentiation of polar subsets characterizes early atopic dermatitis development.Significant correlation of serum IL-22 levels with CCL17 levels in atopic dermatitisCorrelation between serum thymus and activation-regulated chemokine levels and stratum corneum barrier function in healthy individuals and patients with mild atopic dermatitisTopical application of PPARα (but not β/δ or γ) suppresses atopic dermatitis in NC/Nga micePruritus of patients with atopic dermatitis in daily life and their experience of therapeutic effects: results of a web-based questionnaire survey
P50
Q34085721-4DD8B48A-7B8E-4610-9E21-3757247176E1Q35539472-D447305A-B246-4731-B3BF-8618C9BFDAB3Q37098142-153732E2-5113-4260-BB5B-D6490549A2B8Q38195861-B9D15AC4-92F3-4C1E-9FB4-3BE14DE87D37Q38956106-95A436BC-2132-4991-B124-91F1D3DB8F57Q39460105-4DBE1CCE-BD54-4ACB-BBC2-DFDC035B5217Q40484130-C6CC0E2A-09C1-433D-9AA4-B0AB52F89484Q44758668-92AAE949-4BC6-411F-8649-45178779C020Q46716763-139EA4A5-F386-4A21-BDB5-C9B693272908Q50606605-AE7EB4C3-8AE7-4EDB-94CA-6F70EC5A18D4Q50618966-41AC32C6-FF7C-4B03-BECA-F7858FAE7276Q51459379-BEE83BD9-DB15-48D5-BC4B-33B80229AE52Q51698587-0EE4722A-F79C-4CB4-B829-2DDAC357DE91Q52608191-09277B0C-0D3A-4A5D-B98E-8B551797A8AFQ54239245-8FCCBAF0-92EC-4249-AEFC-5327622182C5Q82541854-D4C76C27-9A59-400C-811C-027442990659Q83574653-212CAA32-3F73-4B6F-BE3D-DFD963FFFD93Q84125160-2DAED04C-674A-48AA-BAF6-AB4310D15CC3Q86049055-507DBC8B-FD08-4EE7-9C11-8C1562E85840
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hitokazu Esaki
@ast
Hitokazu Esaki
@en
Hitokazu Esaki
@es
Hitokazu Esaki
@nl
Hitokazu Esaki
@sl
type
label
Hitokazu Esaki
@ast
Hitokazu Esaki
@en
Hitokazu Esaki
@es
Hitokazu Esaki
@nl
Hitokazu Esaki
@sl
prefLabel
Hitokazu Esaki
@ast
Hitokazu Esaki
@en
Hitokazu Esaki
@es
Hitokazu Esaki
@nl
Hitokazu Esaki
@sl
P106
P31
P496
0000-0002-3716-520X